ArticleFrontiers in pharmacology2022

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report.

Juping Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.